Eli Lilly Sues Six Firms Over Black-Market Obesity Drug

Is this about protecting profits from competition or protecting patients from a dangerous black market?

Published AUG 13

Eli Lilly Sues Six Firms Over Black-Market Obesity Drug

story

Above: Stock Photo of Eli Lilly and Company logo on a smartphone. Image credit: Cheng Xin/Getty Images

The Spin

Narrative A

Unapproved retatrutide sold by shady medical spas and fake research labs is a genuine public health crisis, and Lilly is right to go after every compounding pharmacy and online seller pushing this junk on vulnerable people. These black-market products come from unregulated foreign manufacturers with zero oversight, and calling them medicine is a flat-out lie.

Max Marchione on X Eli Lilly and Company

Narrative B

This lawsuit just proves that this product actually works, and now Big Pharma wants to shut down the competition to protect its own profits. This is about a $700 billion company that ignored a 14,000-listing black market for years and only acted once sales got cannibalized. If safety was the real concern, verification systems would have existed long ago.

Mgoes (bio/acc) on X

Joe Vargas on X